Reply

J Allergy Clin Immunol. 2020 Sep;146(3):683-684. doi: 10.1016/j.jaci.2020.05.053. Epub 2020 Jul 24.

Authors

Peter Howarth¹, Claus Bachert², Ana Sousa³, Robert Chan⁴

Affiliations

¹ Global Specialty & Primary Care, GSK House, Brentford, Middlesex, United Kingdom. Electronic address: peter.h.howarth@gsk.com.
² Upper Airways Research Laboratory, University of Ghent, Ghent, Belgium.
³ Respiratory Therapeutic Unit, GSK, Stockley Park, United Kingdom.
⁴ GSK Research & Development, Stevenage, United Kingdom.

PMID: 32713687
DOI: 10.1016/j.jaci.2020.05.053

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Asthma*
Humans
Phenotype
Pulmonary Eosinophilia*

Substances

Antibodies, Monoclonal, Humanized
mepolizumab